SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950103-17-006747
Filing Date
2017-07-14
Accepted
2017-07-14 12:31:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1782495
2 GRAPHIC image_002.jpg GRAPHIC 4896
3 GRAPHIC image_006.gif GRAPHIC 12230
4 GRAPHIC image_006.jpg GRAPHIC 4850
5 GRAPHIC image_007.gif GRAPHIC 1694
6 GRAPHIC image_007.jpg GRAPHIC 3954
7 GRAPHIC image_008.gif GRAPHIC 10883
8 GRAPHIC image_008.jpg GRAPHIC 3954
9 GRAPHIC image_009.gif GRAPHIC 7034
10 GRAPHIC image_009.jpg GRAPHIC 31127
11 GRAPHIC image_010.gif GRAPHIC 10116
12 GRAPHIC p004.jpg GRAPHIC 141001
  Complete submission text file 0000950103-17-006747.txt   2103680
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01626 | Film No.: 17965093
SIC: 2836 Biological Products, (No Diagnostic Substances)